These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 23168528)

  • 41. Ceramide 1-Phosphate Increases P-Glycoprotein Transport Activity at the Blood-Brain Barrier via Prostaglandin E2 Signaling.
    Mesev EV; Miller DS; Cannon RE
    Mol Pharmacol; 2017 Apr; 91(4):373-382. PubMed ID: 28119480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FTY720 modulates human oligodendrocyte progenitor process extension and survival.
    Miron VE; Jung CG; Kim HJ; Kennedy TE; Soliven B; Antel JP
    Ann Neurol; 2008 Jan; 63(1):61-71. PubMed ID: 17918267
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fingolimod impedes Schwann cell-mediated myelination: implications for the treatment of immune neuropathies?
    Köhne A; Stettner M; Jangouk P; Dehmel T; Hartung HP; Lehmann HC; Kieseier BC
    Arch Neurol; 2012 Oct; 69(10):1280-9. PubMed ID: 22751954
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antinociceptive effects of FTY720 during trauma-induced neuropathic pain are mediated by spinal S1P receptors.
    Zhang DD; Linke B; Suo J; Zivkovic A; Schreiber Y; Ferreirós N; Henke M; Geisslinger G; Stark H; Scholich K
    Biol Chem; 2015 Jun; 396(6-7):783-94. PubMed ID: 25720064
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurological S1P signaling as an emerging mechanism of action of oral FTY720 (fingolimod) in multiple sclerosis.
    Lee CW; Choi JW; Chun J
    Arch Pharm Res; 2010 Oct; 33(10):1567-74. PubMed ID: 21052934
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Sphingosine-1-phosphate signaling system and the innovative mechanism of action of fingolimod in treatment of multiple sclerosis: review of foreign literature].
    Shmyrev VI; Kryzhanovskiĭ SM; Danilycheva IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(2 Pt 2):93-7. PubMed ID: 22677684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury.
    Natarajan V; Dudek SM; Jacobson JR; Moreno-Vinasco L; Huang LS; Abassi T; Mathew B; Zhao Y; Wang L; Bittman R; Weichselbaum R; Berdyshev E; Garcia JG
    Am J Respir Cell Mol Biol; 2013 Jul; 49(1):6-17. PubMed ID: 23449739
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sphk1/S1P/S1PR1 Signaling is Involved in the Development of Autoimmune Thyroiditis in Patients and NOD.H-2
    Han C; He X; Xia X; Guo J; Liu A; Liu X; Wang X; Li C; Peng S; Zhao W; Zhou M; Shi X; Li Y; Li Y; Shan Z; Teng W
    Thyroid; 2019 May; 29(5):700-713. PubMed ID: 30963819
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis.
    Mehling M; Johnson TA; Antel J; Kappos L; Bar-Or A
    Neurology; 2011 Feb; 76(8 Suppl 3):S20-7. PubMed ID: 21339487
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Constitutive androstane receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier.
    Wang X; Sykes DB; Miller DS
    Mol Pharmacol; 2010 Sep; 78(3):376-83. PubMed ID: 20547735
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Roles of P-glycoprotein and multidrug resistance protein in transporting para-aminosalicylic acid and its N-acetylated metabolite in mice brain.
    Hong L; Xu C; O'Neal S; Bi HC; Huang M; Zheng W; Zeng S
    Acta Pharmacol Sin; 2014 Dec; 35(12):1577-85. PubMed ID: 25418377
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mapping pathways downstream of sphingosine 1-phosphate subtype 1 by differential chemical perturbation and proteomics.
    Gonzalez-Cabrera PJ; Hla T; Rosen H
    J Biol Chem; 2007 Mar; 282(10):7254-64. PubMed ID: 17218309
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Essential requirement for sphingosine kinase 2 in a sphingolipid apoptosis pathway activated by FTY720 analogues.
    Don AS; Martinez-Lamenca C; Webb WR; Proia RL; Roberts E; Rosen H
    J Biol Chem; 2007 May; 282(21):15833-42. PubMed ID: 17400555
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sphingosine 1-phosphate signaling contributes to cardiac inflammation, dysfunction, and remodeling following myocardial infarction.
    Zhang F; Xia Y; Yan W; Zhang H; Zhou F; Zhao S; Wang W; Zhu D; Xin C; Lee Y; Zhang L; He Y; Gao E; Tao L
    Am J Physiol Heart Circ Physiol; 2016 Jan; 310(2):H250-61. PubMed ID: 26589326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Research progress of the selective sphingosine-1-phosphate receptor 1 agonists].
    Tian YL; Jin J; Wang XJ
    Yao Xue Xue Bao; 2012 Jan; 47(1):7-17. PubMed ID: 22493799
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sphingosine-1-phosphate-induced airway hyper-reactivity in rodents is mediated by the sphingosine-1-phosphate type 3 receptor.
    Trifilieff A; Fozard JR
    J Pharmacol Exp Ther; 2012 Aug; 342(2):399-406. PubMed ID: 22570366
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Involvement of P-glycoprotein and multidrug resistance associated protein 1 in the transport of tanshinone IIB, a primary active diterpenoid quinone from the roots of Salvia miltiorrhiza, across the blood-brain barrier.
    Zhou ZW; Chen X; Liang J; Yu XY; Wen JY; Zhou SF
    Drug Metab Lett; 2007 Aug; 1(3):205-17. PubMed ID: 19356045
    [TBL] [Abstract][Full Text] [Related]  

  • 58. FTY720, an immunomodulatory sphingolipid mimetic: translation of a novel mechanism into clinical benefit in multiple sclerosis.
    Baumruker T; Billich A; Brinkmann V
    Expert Opin Investig Drugs; 2007 Mar; 16(3):283-9. PubMed ID: 17302523
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1-phosphate receptor signaling in endothelial cells.
    Tauseef M; Kini V; Knezevic N; Brannan M; Ramchandaran R; Fyrst H; Saba J; Vogel SM; Malik AB; Mehta D
    Circ Res; 2008 Nov; 103(10):1164-72. PubMed ID: 18849324
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fingolimod reduces neuropathic pain behaviors in a mouse model of multiple sclerosis by a sphingosine-1 phosphate receptor 1-dependent inhibition of central sensitization in the dorsal horn.
    Doolen S; Iannitti T; Donahue RR; Shaw BC; Grachen CM; Taylor BK
    Pain; 2018 Feb; 159(2):224-238. PubMed ID: 29140922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.